<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Science News &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/category/news/science-news/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 16 May 2026 16:34:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Science News &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Blood Test Detects Tumor DNA to Guide Treatment in Advanced Cancer Cases</title>
		<link>https://bioengineer.org/new-blood-test-detects-tumor-dna-to-guide-treatment-in-advanced-cancer-cases/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 16:34:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-blood-test-detects-tumor-dna-to-guide-treatment-in-advanced-cancer-cases/</guid>

					<description><![CDATA[In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tailor cancer treatment by harnessing insights from circulating tumour DNA (ctDNA) found in blood plasma. This novel biomarker has the potential to revolutionize therapeutic strategies for patients suffering from oligometastatic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351880</post-id>	</item>
		<item>
		<title>Transitional Care Boosts Heart Failure Outcomes in Elders</title>
		<link>https://bioengineer.org/transitional-care-boosts-heart-failure-outcomes-in-elders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 15:41:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/transitional-care-boosts-heart-failure-outcomes-in-elders/</guid>

					<description><![CDATA[In an era where the global population is rapidly aging, heart failure remains a formidable challenge in geriatric medicine. The burden of this chronic condition places immense strain not only on patients but also on healthcare systems worldwide, necessitating innovative strategies to improve outcomes for older adults. Recent research has illuminated the critical role transitional [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351877</post-id>	</item>
		<item>
		<title>Low-Power Enhanced I2C Controller: RTL to GDSII</title>
		<link>https://bioengineer.org/low-power-enhanced-i2c-controller-rtl-to-gdsii/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 15:38:03 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/low-power-enhanced-i2c-controller-rtl-to-gdsii/</guid>

					<description><![CDATA[In an era where energy efficiency and miniaturization define the future trajectory of integrated circuits, a groundbreaking advancement in communication protocols has emerged, promising to redefine low-power electronic design. Researchers K, G., S, A., V, A., and their team have unveiled a pioneering approach that enhances the widely utilized Inter-Integrated Circuit (I2C) bus controller by [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351872</post-id>	</item>
		<item>
		<title>Gymnopilus Mushrooms Yield Antibacterial Gymnopilin A10, Gymnoprenol B13</title>
		<link>https://bioengineer.org/gymnopilus-mushrooms-yield-antibacterial-gymnopilin-a10-gymnoprenol-b13/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 15:35:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gymnopilus-mushrooms-yield-antibacterial-gymnopilin-a10-gymnoprenol-b13/</guid>

					<description><![CDATA[In an exciting leap forward for natural product chemistry and plant pathology, researchers have uncovered a novel antibacterial agent from the bitter and hallucinogenic mushroom Gymnopilus orientispectabilis, native to East Asia. This breakthrough shines a spotlight on a class of compounds known as polyisoprenepolyol esters, specifically the gymnopilins, which not only exhibit hallucinogenic properties but [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351870</post-id>	</item>
		<item>
		<title>Uncovering C. elegans Immunity via Genetic Screens</title>
		<link>https://bioengineer.org/uncovering-c-elegans-immunity-via-genetic-screens/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 11:52:05 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/uncovering-c-elegans-immunity-via-genetic-screens/</guid>

					<description><![CDATA[In the absence of specialized immune cells, the nematode Caenorhabditis elegans has evolved an extraordinary network of cross-tissue signalling circuits to defend itself against pathogens. Recent advances in genetic screens have unveiled the intricate communication pathways that connect neurons, intestines, epidermis, and even the germline in orchestrating immune responses and behavioural adaptations. These findings challenge [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351865</post-id>	</item>
		<item>
		<title>Congenital Heart Disease’s Lasting Impact on Brain Health</title>
		<link>https://bioengineer.org/congenital-heart-diseases-lasting-impact-on-brain-health/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 11:27:01 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/congenital-heart-diseases-lasting-impact-on-brain-health/</guid>

					<description><![CDATA[The Hidden Toll: How Congenital Heart Disease Shapes Brain Health Across a Lifetime Congenital heart disease (CHD), a structural anomaly present at birth affecting the heart and its function, has long been regarded primarily as a cardiovascular concern. Yet emerging research is shedding light on a striking and increasingly apparent truth: the condition’s impact extends [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351861</post-id>	</item>
		<item>
		<title>Metabolic Stress Worsens Parkinson’s via Mitochondrial Ferroptosis</title>
		<link>https://bioengineer.org/metabolic-stress-worsens-parkinsons-via-mitochondrial-ferroptosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 10:58:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/metabolic-stress-worsens-parkinsons-via-mitochondrial-ferroptosis/</guid>

					<description><![CDATA[In a groundbreaking study poised to reshape our understanding of neurodegenerative diseases, researchers have unveiled a compelling link between metabolic stress and the worsening of Parkinson’s disease (PD) pathology. The research, led by Zheng, Huang, Wang, and colleagues, highlights how disruptions in cellular metabolism trigger mitochondrial dysfunction and a specialized form of cell death known [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351859</post-id>	</item>
		<item>
		<title>Four New Hydroxyl Fatty Acids from Bacillus sp.</title>
		<link>https://bioengineer.org/four-new-hydroxyl-fatty-acids-from-bacillus-sp/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 10:41:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/four-new-hydroxyl-fatty-acids-from-bacillus-sp/</guid>

					<description><![CDATA[In a groundbreaking advancement that bridges marine microbiology and natural product chemistry, researchers have identified four novel hydroxyl fatty acids, specifically gambaoic acids A-C and gambaoic B methyl ester, sourced from a Bacillus species derived from shrimp Jeotgal. This discovery, detailed in the latest correction note published in the Journal of Antibiotics, signals a promising [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351856</post-id>	</item>
		<item>
		<title>Validating B-IPQ Short Form for Older Colombians</title>
		<link>https://bioengineer.org/validating-b-ipq-short-form-for-older-colombians/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 10:35:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/validating-b-ipq-short-form-for-older-colombians/</guid>

					<description><![CDATA[In a remarkable advancement poised to influence geriatric healthcare frameworks across Latin America, a team of researchers has meticulously adapted and validated a shortened version of the Brief Illness Perception Questionnaire (B-IPQ) tailored specifically for older Colombian adults. This scientific endeavor, recently published in BMC Geriatrics, pioneers a culturally and demographically sensitive tool that allows [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351853</post-id>	</item>
		<item>
		<title>Narrative Medicine Boosts Residency Training Outcomes</title>
		<link>https://bioengineer.org/narrative-medicine-boosts-residency-training-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 10:33:01 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/narrative-medicine-boosts-residency-training-outcomes/</guid>

					<description><![CDATA[In recent years, the medical education landscape has witnessed a paradigm shift as educators seek innovative approaches to enhance not only clinical competence but also the humanistic aspects of care. A groundbreaking new study published in Scientific Reports in 2026 sheds light on the transformative potential of narrative medicine-based education in residency training. This comprehensive [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351848</post-id>	</item>
		<item>
		<title>Perinatal and Early Childhood Factors in PFAPA Persistence</title>
		<link>https://bioengineer.org/perinatal-and-early-childhood-factors-in-pfapa-persistence/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 09:26:01 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/perinatal-and-early-childhood-factors-in-pfapa-persistence/</guid>

					<description><![CDATA[In a groundbreaking stride toward understanding childhood autoinflammatory disorders, recent research has unveiled critical insights into PFAPA syndrome—a condition characterized by periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. This enigmatic syndrome, predominantly affecting young children, manifests as recurrent episodes of fever accompanied by inflammation in various tissues, wreaking significant disruption on the lives of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351844</post-id>	</item>
		<item>
		<title>New Actinomycin Derivatives Target Malaria More Selectively</title>
		<link>https://bioengineer.org/new-actinomycin-derivatives-target-malaria-more-selectively/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 05:40:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-actinomycin-derivatives-target-malaria-more-selectively/</guid>

					<description><![CDATA[In a groundbreaking leap forward for malaria treatment, researchers have unveiled a new class of actinomycin derivatives that exhibit markedly improved selectivity against malaria parasites. This discovery emerges from an extensive screening of a diverse Streptomyces culture library, spotlighting the untapped potential of natural products in the fight against persistent parasitic diseases. The study, conducted [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351842</post-id>	</item>
		<item>
		<title>Mobile App Enhances Exercise for Older Adults’ Cognition</title>
		<link>https://bioengineer.org/mobile-app-enhances-exercise-for-older-adults-cognition/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 05:34:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mobile-app-enhances-exercise-for-older-adults-cognition/</guid>

					<description><![CDATA[In a groundbreaking development that could redefine health management for seniors, researchers have engineered a mobile exercise management application tailored specifically for older adults experiencing mild cognitive impairment (MCI). This pivotal innovation transcends traditional exercise regimes, integrating personalized exercise preferences with cutting-edge technology to offer a bespoke wellness companion for a vulnerable population segment. The [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351839</post-id>	</item>
		<item>
		<title>Botulinum Toxin Reduces Urinary Retention Post-Hemorrhoidopexy</title>
		<link>https://bioengineer.org/botulinum-toxin-reduces-urinary-retention-post-hemorrhoidopexy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 05:32:20 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/botulinum-toxin-reduces-urinary-retention-post-hemorrhoidopexy/</guid>

					<description><![CDATA[In an innovative stride toward mitigating postoperative complications in colorectal surgery, recent research has illuminated the promising role of intrasphincteric botulinum toxin injections in reducing urinary retention following stapled hemorrhoidopexy. This groundbreaking randomized, double-blind, placebo-controlled trial paves the way for enhancing patient recovery and quality of life after a commonly performed surgical procedure for hemorrhoidal [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351834</post-id>	</item>
		<item>
		<title>Blood Metal Exposure Linked to Puberty Timing</title>
		<link>https://bioengineer.org/blood-metal-exposure-linked-to-puberty-timing/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 05:21:00 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/blood-metal-exposure-linked-to-puberty-timing/</guid>

					<description><![CDATA[In an era where environmental pollutants stealthily infiltrate our daily lives, a groundbreaking study published in Pediatric Research unearths the intricate connections between potentially toxic metal exposure and pubertal development in children across the United States. The research, leveraging data from the National Health and Nutrition Examination Survey (NHANES) spanning 2013 to 2016, shines a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351830</post-id>	</item>
		<item>
		<title>rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia</title>
		<link>https://bioengineer.org/raav8-hmr-001-boosts-liver-gene-therapy-in-hemophilia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 05:08:31 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/raav8-hmr-001-boosts-liver-gene-therapy-in-hemophilia/</guid>

					<description><![CDATA[In a groundbreaking advancement for gene therapy, researchers have unveiled two novel bioengineered AAV8 vectors—HMR-001 and its codon-optimized counterpart HMR-001z—that demonstrate remarkable efficacy in restoring hemostasis in hemophilia A, a severe bleeding disorder caused by factor VIII deficiency. This pioneering study addresses the critical limitations of current hemophilia therapies as well as earlier gene delivery [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351828</post-id>	</item>
		<item>
		<title>Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma</title>
		<link>https://bioengineer.org/pembrolizumab-and-lenvatinib-trial-for-mucosal-melanoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 03:28:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/pembrolizumab-and-lenvatinib-trial-for-mucosal-melanoma/</guid>

					<description><![CDATA[In a groundbreaking development that may redefine the therapeutic landscape for mucosal melanoma, researchers have unveiled promising results from a phase II peri-operative clinical trial combining pembrolizumab and lenvatinib. This study, led by Mao, Lai, Zheng, and colleagues, and recently published in Nature Communications, addresses the critical need for effective treatment modalities against this notoriously [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351826</post-id>	</item>
		<item>
		<title>Carboplatin ± Nivolumab in Metastatic TNBC Trial</title>
		<link>https://bioengineer.org/carboplatin-%c2%b1-nivolumab-in-metastatic-tnbc-trial/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 02:27:19 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/carboplatin-%c2%b1-nivolumab-in-metastatic-tnbc-trial/</guid>

					<description><![CDATA[In a groundbreaking advancement that could reshape the therapeutic landscape for metastatic triple-negative breast cancer (mTNBC), researchers have conducted a pivotal randomized phase II trial exploring the efficacy of carboplatin with or without the addition of nivolumab. This study, soon to be published in Nature Communications, unveils promising clinical insights into integrating immune checkpoint blockade [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351823</post-id>	</item>
		<item>
		<title>New Numeracy Screener Developed for Preschoolers</title>
		<link>https://bioengineer.org/new-numeracy-screener-developed-for-preschoolers/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 02:20:00 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-numeracy-screener-developed-for-preschoolers/</guid>

					<description><![CDATA[In the ever-evolving landscape of early childhood education, a groundbreaking development in the realm of numeracy assessment has just emerged, promising to redefine how we understand and support the mathematical foundations of preschool-aged children. The Number Farm, a newly developed and pilot-tested numeracy screener, aims to revolutionize early childhood numeracy evaluation by offering an innovative [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351820</post-id>	</item>
		<item>
		<title>Genetic Dosage Influences Parkinson’s Cognitive Decline</title>
		<link>https://bioengineer.org/genetic-dosage-influences-parkinsons-cognitive-decline/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 16 May 2026 01:51:01 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/genetic-dosage-influences-parkinsons-cognitive-decline/</guid>

					<description><![CDATA[In an ambitious and groundbreaking study published in npj Parkinson’s Disease, researchers have unveiled revolutionary insights into the genetic underpinnings governing cognitive decline in Parkinson’s disease (PD). This extensive 15-year meta-analysis, synthesizing data from 24 international cohorts, heralds a new era in understanding the intricate role that multi-locus genetic dosage plays in shaping the trajectory [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">351818</post-id>	</item>
	</channel>
</rss>
